ENSG00000291006 and ovarian carcinoma: Whereas the combination of treatment with 3-MA, the number of colonies formed in ovarian cancer cells treated with 3-MA was significantly lower than that in the group treated with cisplatin or niraparib alone, and the difference in colony formation increased by knockdown of LOC730101 was reverted (Figs. S5C and S5D).